Sernova Corp. (id:13619 SVA)
0.230 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 2:55:02 PM)
Exchange closed, opens in 1 day 18 hours
About Sernova Corp.
Market Capitalization 76.45M
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.
| Headquarters (address) |
The Stiller Centre London N6G 4X8 ON Canada |
| Phone | 519 858 5126 |
| Website | https://www.sernova.com |
| Employees | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | SVA |
| Exchange | Toronto Stock Exchange |
| Currency | CAD |
| 52 week range | 0.200 - 0.770 |
| Market Capitalization | 76.45M |
| P/E trailing | -1.81 |
| P/E forward | -3.36 |
| Price/Book | -5.69 |
| Beta | 1.32 |
| EPS | -0.130 |
| EPS Canada (ID:82, base:722) | 1.84 |